S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angela Davies, MD
University of California, Davis
Principal Investigator - Chris H. Takimoto, MD, PhD
Institute for Drug Development
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Community Oncology Group at Cleveland Clinic Cancer Center
Independence, Ohio, United States
- Cleveland Clinic - Wooster
Wooster, Ohio, United States
- Brooke Army Medical Center
Fort Sam Houston, Texas, United States
- Wilford Hall Medical Center
Lackland Air Force Base, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- St. Joseph Hospital Community Cancer Center
Bellingham, Washington, United States
- Olympic Hematology and Oncology
Bremerton, Washington, United States
- Skagit Valley Hospital Cancer Care Center
Mount Vernon, Washington, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Group Health Central Hospital
Seattle, Washington, United States
- Harborview Medical Center
Seattle, Washington, United States
- Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
Seattle, Washington, United States
- University Cancer Center at University of Washington Medical Center
Seattle, Washington, United States
- North Puget Oncology at United General Hospital
Sedro-Woolley, Washington, United States
- Cancer Care Northwest - Spokane South
Spokane, Washington, United States
- Wenatchee Valley Medical Center
Wenatchee, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2003
- Primary completion
- 30 Sept 2006
- Completion
- 31 Dec 2007
- Last update posted
- 3 Apr 2015
- Registered enrollment
- 78
- Registry id
- NCT00049400
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.